Market News

The expansion includes three high-speed packaging lines — a syringe assembly machine, an auto-injector assembly machine and a top-load cartoner.

The acquisition will enhance senior-level expertise, which will support clients from Diamond’s regulatory affairs business in specialist areas such as gene and cell therapies.

Submit your entry before 1 July 2020!

Date alteration taken at the request of exhibitors to ensure the international character of China’s largest pharma exhibition.

Decisions by individual European countries to ensure medicines availability during the COVID-19 pandemic are complicating international supply chains, industry association says

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

Syntegon to showcase flexible solutions for small and microbatches, new developments for liquid filling and assembly, as well as AI-enhanced product safety.

New solutions will provide critical transparency to the life sciences supply chain, mobilizing companies to rapidly react to unforeseen disruptions and ensure medicine supply.

Importing countries’ embassies are being asked to submit detailed requests for the key medicines amid COVID-19 pandemic

Companies to combine innovative technologies to develop an adjuvanted coronavirus vaccine 

The CultureOne separator system uses product-contact parts that are replaceable and made from recyclable material.

Zynamite is an all-natural evidence-based nootropic and sports performance ingredient, supported by clinical studies.

Despite current travel restrictions, the machine manufacturer manages to perform factory acceptance tests (FATs) via a live stream at its manufacturing facility.

Independent Data Monitoring Committee (IDMC) recommends unblind Phase III trial of Tagrisso 2 years ahead of schedule.

Blockchain technology could prove to be the missing link for global healthcare supply chains exposed by the COVID-19 pandemic in building resilience and galvanizing efficiency, transparency and authenticity, according to market research firm, GlobalDat...

The biotech pioneer is one of the first companies to develop corporate partnerships in this application of artificial intelligence (AI) for drug discovery.

The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications.

The FectoVIR-AAV transfection reagent achieves large-scale transient transfection resulting in up to a 10-fold increase in AAV functional viral titer yields in suspension cell systems.

Move comes 24 hours after US President warns of "retaliation" if export ban was not lifted

Symphogen becomes the antibody center of excellence within Servier.

The platform enables collaboration between pharmaceutical institutions, healthcare and academic researchers to generate valuable insights and advance medical research.

Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article.

The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered with ChargePoint Technology to ensure the sterility of its drug substance mixing process.

Study data support blood test's ability to detect 50 types of cancer and identify where in the body the cancer is located.

Specialist cleanroom microbiology solutions company offers the new SAS Super Pinocchio CR compressed air sampling device.

Joint venture between Spinview and VR Media Technology creates device that provides accurate and fast detection of infectious people with far greater clarity than any single parameter test available today.

The European Medicines Agency (EMA) said Monday it will only issue electronically signed and authenticated certificates for human and veterinary medicines in place of printed ones so it can continue to provide the documents during the COVID-19 pandemic...

Indian contract development and manufacturing organisation, Suven Pharmaceuticals, has warned it cannot export finished products due to a shortage of raw materials following the country’s recent lockdown to fight the COVID-19 pandemic.

Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide.

Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections.

The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.

The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.

The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose.

Fierce competition in the low cost, high volume API sector is forcing suppliers to invest in capacity and accelerate throughout. 

Despite consolidation, competition between manufacturers is fierce and the generic drug market continues to grow.

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.

This documentation will enable customers worldwide to leverage the D-Flex disposable pen system for their combination product development.

Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems.

The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.

A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.

Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts.

Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate".

Netherlands-based specialty pharmaceutical company Pharming has received US Food and Drug Administration (FDA) approval for its new biologics facility in the Netherlands which it says will ensure sufficient manufacturing capacity for its acute heredita...

Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.

Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.

Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.

CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide.

Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.

The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure".

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ...

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy.

The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life.

Unlocking the potential of Raman spectroscopy as a high throughput analytical technique for monitoring cell culture in mini bioreactors.

Sanofi's plans to create a European company to manufacture and market active pharmaceutical ingredients (APIs) should help to balance the region's heavy reliance on sourcing them from Asian markets, the French pharmaceutical firm said Monday.

Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.

The future of value-added medicines will see gamification transforming the engagement of therapies.

The investment will support continued expansion into the fast-growing gene therapy segment, including new developments that will enable a range of best-in-class solutions for viral manufacturing.

The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.

Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the company

Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.

Event move ensures extra precautions and safety measures taken

The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Bundling of competencies optimizes workflow of customer projects.

Trijardy XR is a once-daily therapy combining three well-established treatments in one pill.

Agreement will facilitate clinical trial translations in China.

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.

€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.

The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants.

The $470 million investment will support a state-of-the-art facility that produces injectable products and delivery devices.

No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy.

The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system.

The potential acquisition will see UK CDMO NextPharma develop and broaden its technology offering into lipid-based finished dosage forms

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.

Business to focus on intelligent and sustainable technologies.

BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.

The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...

PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases.

Multiple options provide increased flexibility for sponsors.

The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.

India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility.

CPHI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPHI, including CPHI North America—the only event to bring the entire North American pharmac...

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine.

The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination.

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data.

Expands company's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial.

Drug industry expectations of packaging are evolving with developers now seeking techs that help patients get more from their medicines.

Mutations in the RIPK1 gene responsible for CRIA syndrome.

Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches.

Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.

Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapy.

Botox and Botox Cosmetic (onabotulinumtoxinA) hold 14 therapeutic and aesthetic indications combined, more than any other neurotoxin in the world.

Next-generation pharmaceutical supply-chain security for tracking product from plant to patient.

Customers and partners look set to benefit from reduced development times and costs of medical drugs.

The investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products.

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020.

The past 12 months have been busy as many companies fought to comply with serialization regulations.

Represents the first biopackaging of its kind made of renewable raw materials.

New CTSuccess service helps to reduce the risk of delays and budget overspend.

The fast-dispersing Zydis formulation could increase compliance with Medication-Assisted Treatment and thus better clinical outcomes.

Smart tags on pills set to improve supply chain security and patient adherence.

The US pharmaceutical industry continues to lead its global peers in terms of innovation and competitiveness, while still ranking high in overall growth potential despite its mature status, according to the results of a survey of 350 global pharmaceuti...

Installation of a SprayVIEW system will help the CDMO to support customers in both innovative and generic inhalation and nasal product development.